Snapdeal ties up with Mapmygenome

The cutthroat competition in the Indian e-commerce market has seen many websites try to outdo each other by offering unique services. Snapdeal seems to be super aggressive as far as expansion is concerned. After cracking partnership with Tata Value Homes, the Delhi based company has tied up with Mapmygenome India to offer DNA testing services.

Founded in 2012, Mapmygenome India is a company that offers a range of services to paint a picture of one’s genetic makeup and suggest ways to lead a better and healthier life. The services offered on Snapdeal include Cardiomap, Genomepatri, Mycalmbeat, and Webneuro. With this service, customers will be able to order personal genomic tests, which will help them identify the ideal lifestyle to lead a healthy and fit life. Mapping the genome aids in predicting, preventing, and treating a number of diseases. Mapmygenome offers tests in between Rs 1,000 to 25,000.

Cardiomap evaluates if you are at risk to heart diseases or diabetes based on your genetics. The service costs Rs 12,000 on Snapdeal. Genomepatri is the most expensive of the lot, priced at Rs 25,000. It essentially studies one’s DNA and suggests ways to change one’s lifestyle to lead a healthier life. Mycalmbeat, priced at Rs 5,000 is described as a personal stress reduction monitor that decreases stress and increases focus on personalized slow breathing. Webneuro, priced at Rs 1,500 is a web based 30 minute test that assesses the cognitive strength and weaknesses of individual. The collaboration will help both companies in reaching out to out 25 Million+ members across the country and enable them to understand the gene-disease interaction better.

Snapdeal has also announced its entry into the hospitality segment with 50,000 products across brands like cookware and bakeware, dining and serving and bar & glassware among others. Last month, Snapdeal raised an undisclosed amount of funding from Ratan Tata. Earlier this year, it had raised $133 Million led by eBay along with Kalaari Capital, Nexus Venture Partners, Bessemer Venture Partners, Intel Capital, and Saama Capital.